Search research articles
Contact Us
Filters
Showing results (21-30 of 64) with videos related to
Page
of 7
Sort By:
Cancer Research
|
July 15, 1990
Antiproliferative and antitumor effects of alpha-interferon in renal cell carcinomas: correlation with the expression of a kidney-associated differentiation glycoprotein
D M Nanus, L M Pfeffer, N H Bander, et al.
Melanoma Research
|
October 1, 1996
Mutation and expression of the low affinity neurotrophin receptor in human malignant melanoma
C Papandreou, T Bogenrieder, F Loganzo, et al.
British Journal of Cancer
|
February 22, 2000
Analysis of the insertion/deletion polymorphism of the human angiotensin converting enzyme (ACE) gene in patients with renal cancer
B A Usmani, M Janeczko, R Shen, et al.
The Journal of Urology
|
January 1, 1990
Infrequent ras oncogene point mutations in renal cell carcinoma
D M Nanus, I R Mentle, R J Motzer, et al.
Cancer Research
|
April 6, 2001
Reduced levels of retinyl esters and vitamin A in human renal cancers
X Guo, D M Nanus, A Ruiz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1989
Flow cytometry as a predictive indicator in patients with operable gastric cancer
D M Nanus, D P Kelsen, D Niedzwiecki, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
October 14, 2000
Interaction of retinoic acid and interferon in renal cancer cell lines
D M Nanus, Y Geng, R Shen, et al.
Cancer Gene Therapy
|
April 7, 2007
Lentiviral vector neutral endopeptidase gene transfer suppresses prostate cancer tumor growth
A Horiguchi, R Zheng, O B Goodman, et al.
Critical Reviews in Oncology/Hematology
|
September 1, 2015
Cytotoxic chemotherapy in the treatment of advanced renal cell carcinoma in the era of targeted therapy
E Diamond, A M Molina, M Carbonaro, et al.
Endocrinology
|
May 10, 2000
Androgen-induced growth inhibition of androgen receptor expressing androgen-independent prostate cancer cells is mediated by increased levels of neutral endopeptidase
R Shen, M Sumitomo, J Dai, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 64) with videos related to
Sort By:
Page
of 7
Cancer Research
|
July 15, 1990
Antiproliferative and antitumor effects of alpha-interferon in renal cell carcinomas: correlation with the expression of a kidney-associated differentiation glycoprotein
D M Nanus, L M Pfeffer, N H Bander, et al.
Melanoma Research
|
October 1, 1996
Mutation and expression of the low affinity neurotrophin receptor in human malignant melanoma
C Papandreou, T Bogenrieder, F Loganzo, et al.
British Journal of Cancer
|
February 22, 2000
Analysis of the insertion/deletion polymorphism of the human angiotensin converting enzyme (ACE) gene in patients with renal cancer
B A Usmani, M Janeczko, R Shen, et al.
The Journal of Urology
|
January 1, 1990
Infrequent ras oncogene point mutations in renal cell carcinoma
D M Nanus, I R Mentle, R J Motzer, et al.
Cancer Research
|
April 6, 2001
Reduced levels of retinyl esters and vitamin A in human renal cancers
X Guo, D M Nanus, A Ruiz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1989
Flow cytometry as a predictive indicator in patients with operable gastric cancer
D M Nanus, D P Kelsen, D Niedzwiecki, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
October 14, 2000
Interaction of retinoic acid and interferon in renal cancer cell lines
D M Nanus, Y Geng, R Shen, et al.
Cancer Gene Therapy
|
April 7, 2007
Lentiviral vector neutral endopeptidase gene transfer suppresses prostate cancer tumor growth
A Horiguchi, R Zheng, O B Goodman, et al.
Critical Reviews in Oncology/Hematology
|
September 1, 2015
Cytotoxic chemotherapy in the treatment of advanced renal cell carcinoma in the era of targeted therapy
E Diamond, A M Molina, M Carbonaro, et al.
Endocrinology
|
May 10, 2000
Androgen-induced growth inhibition of androgen receptor expressing androgen-independent prostate cancer cells is mediated by increased levels of neutral endopeptidase
R Shen, M Sumitomo, J Dai, et al.
Page
of 7